# DeepCell

> AI-powered single-cell imaging platform classifying cells by morphology without markers.

## Why it is interesting

Stanford spinout using computer vision on intact cells — a16z stayed in through Koch-led Series B as morpholomics atlas scaled past 1B images.

## Profile

- **Stage:** other
- **Status:** private
- **Industries:** biotech-life-sciences, ai-ml
- **Coverage:** full
- **Last updated:** 2026-07-24

## Key facts

- Series B (Mar 2022): $73M led by Koch Disruptive Technologies; a16z re-upped (Fierce Biotech)
- Series A (Dec 2020): $20M led by Bow Capital with a16z participation (company press)
- Co-investors not in VCT directory: Koch Disruptive Technologies, Bow Capital, Bridger Healthcare, Horizons Ventures, Casdin Capital
- VCT directory co-investors: none mapped (non-directory syndicates noted above); reviewed 2026-07-24

## Investors in our directory

- https://venturecapitaltracker.com/fund/andreessen-horowitz

---
Source: https://venturecapitaltracker.com/startup/deepcell